Skip to content

Clinical efficacy of Chaihu plus Longgu Oyster soup in the treatment of post-stroke depression and its mechanism based on resting state functional magnetic resonance imaging

Clinical Efficacy Evaluation of Chaihu Plus Longgu Muli Decoction in the Treatment of Post-Stroke Depression and Mechanism Study Based on Resting-State Functional Magnetic Resonance Imaging (rs-fMRI)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001118
Enrollment
Unknown
Registered
2026-04-28
Start date
2024-01-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke depression

Interventions

Treatment group:Chai Hu Long Gu Mu Li Decoction combined with Oxalate Escitalopram

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Western medical diagnosis meets the diagnostic criteria for both stroke and depression; 2) Traditional Chinese medicine diagnosis meets the diagnostic criteria for post-stroke depression; 3) TCM syndrome pattern meets the diagnostic criteria for post-stroke depression with heat depression and Shaoyang disturbing the mind; 4) HAMD-17 scale score between 7-24 indicating mild to moderate depression; 5) Age between 18 and 80 years; 6) Patients receiving Chinese medicine treatment with good compliance; 7) No history of mental illness before onset, and no antidepressant treatment received after onset; 8) Participants or their family members voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) No obvious imaging changes of stroke detected; 2) History of mental illness or family history of mental illness; 3) Presence of severe cardiovascular, liver and kidney, hematopoietic system, or endocrine and immune system diseases; 4) Suicide risk assessment scale (Sad Persons) score =7, with obvious suicidal tendencies; 5) Pregnant or breastfeeding women; 6) Mini-Mental State Examination (MMSE) =21, with moderate to severe cognitive impairment, hearing impairment, or aphasia; 7) Those who do not accept the treatment plan.

Design outcomes

Primary

MeasureTime frame
HAMD-17;

Secondary

MeasureTime frame
Traditional Chinese Medicine Symptom Scale for Post-Stroke Depression (Hot Depression Shaoyang Type);Hamilton Anxiety Scale;Self-Rating Depression Scale;National Institute of Health stroke scale;Barthel;Resting-state functional magnetic resonance imaging;PSQI;

Countries

China

Contacts

Public ContactyuanxinShao

Liaocheng People's Hospital

647685432@qq.com13006594167

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026